Colorectal cancer (CRC) ranks third in cancer incidence and stands as the second leading cause of cancer-related deaths globally. CRC tumorigenesis results from a cumulative set of genetic and epigenetic alterations, disrupting cancer-regulatory processes like cell proliferation, metabolism, angiogenesis, cell death, invasion, and metastasis. Key epigenetic modifications observed in cancers encompass abnormal DNA methylation, atypical histone modifications, and irregularities in noncoding RNAs, such as microRNAs and long noncoding RNAs. The advancement in genomic technologies has positioned these genetic and epigenetic shifts as potential clinical biomarkers for CRC patients. This review concisely covers the fundamental principles of CRC-associated epigenetic changes, and examines in detail their emerging role as biomarkers for early detection, prognosis, and treatment response prediction.
Citations
Citations to this article as recorded by
Influence of Lifestyles on Polyp Burden and Cancer Development in Hereditary Colorectal Cancer Syndromes Hye Kyung Hyun, Ji Soo Park, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim Journal of Gastroenterology and Hepatology.2025; 40(2): 433. CrossRef
The role of suppressor of cytokine signaling 3 in inflammatory bowel disease and its associated colorectal cancer Pengfei Zhang, Bing Pei, Chengxue Yi, Francis Atim Akanyibah, Fei Mao Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(2): 167578. CrossRef
Chronic Kidney Disease Increases Risk of Delayed Post‐Polypectomy Bleeding: A Large‐Scale Propensity Score‐Matched Analysis Hye Kyung Hyun, Nak‐Hoon Son, So Hyeon Gwon, Hyun Chul Lim, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Tae‐Hyun Yoo, Shin‐Wook Kang, Hae‐Ryong Yun, Cheal Wung Huh United European Gastroenterology Journal.2025; 13(5): 759. CrossRef
An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update Susmita Roy, Dikshita Deka, Suresh Babu Kondaveeti, Pavithra Ayyadurai, Sravani Siripragada, Neha Philip, Surajit Pathak, Asim K. Duttaroy, Antara Banerjee Epigenetics.2025;[Epub] CrossRef
Minimum Platelet Count Threshold for Safe Colonoscopic Polypectomy: A Large-Scale Propensity Scored-Matched Analysis Hye Kyung Hyun, Nak-Hoon Son, Cheal Wung Huh, Hyun Chul Lim, So Hyeon Gwon, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim American Journal of Gastroenterology.2025;[Epub] CrossRef
Anthocyanins: From Natural Colorants to Potent Anticancer Agents Muhammad Maaz, Muhammad Tauseef Sultan, Ahmad Mujtaba Noman, Shehnshah Zafar, Naima Tariq, Muzzamal Hussain, Muhammad Imran, Ahmed Mujtaba, Tadesse Fenta Yehuala, Ehab M. Mostafa, Samy Selim, Soad K. Al Jaouni, Suliman A. Alsagaby, Waleed Al Abdulmonem Food Science & Nutrition.2025;[Epub] CrossRef
Hsa-miR-21-5p and Hsa-miR-145-5p Expression: From Normal Tissue to Malignant Changes—Context-Dependent Correlation with Estrogen- and Hypoxia–Vascularization-Related Pathways Genes: A Pilot Study Mateusz Górecki, Aleksandra Żbikowska, Małgorzata Tokłowicz, Stefan Sajdak, Monika Englert-Golon, Mirosław Andrusiewicz International Journal of Molecular Sciences.2025; 26(9): 4461. CrossRef
Epigenetically Regulating Non-coding RNAs in Colorectal Cancer: Promises and Potentials Zahra Taheri, Majid Zaki-Dizaji Middle East Journal of Digestive Diseases.2025; 17(1): 40. CrossRef
Elevated Methylation Contributes to Suppressed Expression of Special AT‐Rich Sequence‐Binding Protein 2 in Colorectal Cancer: A Gene‐Disease Association Study Weitong Cui, Cong Lu, Huaru Xue, Lei Wei, Shuai Li, Lianzheng Su, Dianfang Wei, Xiaoyu Feng, Kai Wang, Chao Song Health Science Reports.2025;[Epub] CrossRef
Integrative multi-omics identification and functional validation of potential targets linking metabolism–immune–colorectal cancer causal pathway Zequn Zheng, Xiaoling Xu Frontiers in Immunology.2025;[Epub] CrossRef
Identification of isatin-triazole-benzenesulfonamide hybrids as dual hCA IX/XII and c-met inhibitors with hypoxia-mediated chemo-sensitizing activity Wagdy M. Eldehna, Mohamed R. Elnagar, Simone Giovannuzzi, Amr Tayel, Maha-Hamadien Abdulla, Noura S. Alhassan, Moataz A. Shaldam, Alessio Nocentini, Claudiu T. Supuran, Haytham O. Tawfik Bioorganic Chemistry.2025; 166: 109071. CrossRef
TET methylcytosine dioxygenases in cancer: Orchestrators of pathogenesis, immunity, immunotherapy, and chemoresistance Yukai Zhang, Jian Li, Juan Liu International Immunopharmacology.2025; 167: 115622. CrossRef
miR-3065-5p and miR-26a-5p as Clinical Biomarkers in Colorectal Cancer: A Translational Study Berenice Carbajal-López, Antonio Daniel Martínez-Gutierrez, Eduardo O. Madrigal-Santillán, Germán Calderillo-Ruiz, José Antonio Morales-González, Jossimar Coronel-Hernández, Joey Lockhart, Oliver Millan-Catalan, Monica G. Mendoza-Rodriguez, Leonardo S. Li Cancers.2024; 16(21): 3649. CrossRef